• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆抗PRTN3 IgG和IgM自身抗体:早期检测肺腺癌的新型生物标志物。

Plasma anti-PRTN3 IgG and IgM autoantibodies: novel biomarkers for early detection of lung adenocarcinoma.

作者信息

Li Yutong, Wang Linhong, Chen Fengqi, Liao Rulan, Li Jing, Cao Xiaobin, Ouyang Songyun, Dai Liping, Du Renle

机构信息

Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan, China.

Beijing Genomics Institution (BGI) College, Zhengzhou University, Zhengzhou, Henan, China.

出版信息

Front Immunol. 2025 Feb 14;16:1534078. doi: 10.3389/fimmu.2025.1534078. eCollection 2025.

DOI:10.3389/fimmu.2025.1534078
PMID:40028338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11868074/
Abstract

BACKGROUND

Proteinase 3 (PRTN3) has been recognized as a crucial target for anti-neutrophil cytoplasmic autoantibody. However, the relationship between anti-PRTN3 autoantibody and cancer remains largely unexplored.

METHODS

Immunohistochemistry was used to detect the level of PRTN3 in lung adenocarcinoma (LUAD) tissue array. Enzyme-linked immunosorbent assay was conducted to measure anti-PRTN3 IgG and IgM autoantibodies in plasma from patients with early- and advanced-stage LUAD, benign pulmonary nodules (BPN) and normal control (NC). Western blotting and immunofluorescence staining were performed to confirm the presence of plasma immune response to PRTN3.

RESULTS

PRTN3 protein was highly expressed in LUAD tissues. Elevated plasma levels of anti-PRTN3 IgG and IgM autoantibodies were also detected in LUAD, especially in early LUAD. The AUC of anti-PRTN3 IgG autoantibodies in the diagnosis of early LUAD from NC was 0.782, and from BPN was 0.761. When CEA and anti-PRTN3 autoantibodies were combined, the AUC for the diagnosis of early LUAD was significantly higher than that of CEA alone. The presence of a plasma immune response to PRTN3 in LUAD was also confirmed.

CONCLUSION

Anti-PRTN3 IgG and IgM autoantibodies maybe early biomarkers to differentiate LUAD from NC and BPN.

摘要

背景

蛋白酶3(PRTN3)已被公认为抗中性粒细胞胞浆自身抗体的关键靶点。然而,抗PRTN3自身抗体与癌症之间的关系在很大程度上仍未得到探索。

方法

采用免疫组织化学法检测肺腺癌(LUAD)组织芯片中PRTN3的水平。采用酶联免疫吸附试验检测早期和晚期LUAD患者、良性肺结节(BPN)患者及正常对照(NC)血浆中抗PRTN3 IgG和IgM自身抗体。进行蛋白质免疫印迹和免疫荧光染色以确认血浆对PRTN3的免疫反应的存在。

结果

PRTN3蛋白在LUAD组织中高表达。在LUAD患者中也检测到血浆中抗PRTN3 IgG和IgM自身抗体水平升高,尤其是在早期LUAD患者中。抗PRTN3 IgG自身抗体在诊断早期LUAD与NC时的曲线下面积(AUC)为0.782,与BPN时为0.761。当癌胚抗原(CEA)与抗PRTN3自身抗体联合使用时,诊断早期LUAD的AUC显著高于单独使用CEA时。还证实了LUAD患者血浆对PRTN3存在免疫反应。

结论

抗PRTN3 IgG和IgM自身抗体可能是区分LUAD与NC和BPN的早期生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/cbc1b5c0a7fe/fimmu-16-1534078-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/37302dff8664/fimmu-16-1534078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/29496c928427/fimmu-16-1534078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/5951ec9ddb16/fimmu-16-1534078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/5c5649d51d2e/fimmu-16-1534078-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/8ebe1a2f73f1/fimmu-16-1534078-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/cbc1b5c0a7fe/fimmu-16-1534078-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/37302dff8664/fimmu-16-1534078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/29496c928427/fimmu-16-1534078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/5951ec9ddb16/fimmu-16-1534078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/5c5649d51d2e/fimmu-16-1534078-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/8ebe1a2f73f1/fimmu-16-1534078-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b38e/11868074/cbc1b5c0a7fe/fimmu-16-1534078-g006.jpg

相似文献

1
Plasma anti-PRTN3 IgG and IgM autoantibodies: novel biomarkers for early detection of lung adenocarcinoma.血浆抗PRTN3 IgG和IgM自身抗体:早期检测肺腺癌的新型生物标志物。
Front Immunol. 2025 Feb 14;16:1534078. doi: 10.3389/fimmu.2025.1534078. eCollection 2025.
2
A Novel IgG-IgM Autoantibody Panel Enhances Detection of Early-stage Lung Adenocarcinoma from Benign Nodules.一种新型IgG-IgM自身抗体检测组合提高了从良性结节中检测早期肺腺癌的能力。
Genomics Proteomics Bioinformatics. 2025 Jan 15;22(6). doi: 10.1093/gpbjnl/qzae085.
3
Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer.针对COPT1的血浆IgG和IgM自身抗体作为检测非小细胞肺癌的潜在生物标志物。
Front Immunol. 2025 Apr 11;16:1455095. doi: 10.3389/fimmu.2025.1455095. eCollection 2025.
4
A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.IgM 自身抗体和癌胚抗原联合诊断模型用于肺腺癌的早期检测。
Front Immunol. 2022 Jan 24;12:728853. doi: 10.3389/fimmu.2021.728853. eCollection 2021.
5
The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.免疫球蛋白 A 和免疫球蛋白 G 联合针对转录中介因子-1γ的自身抗体有助于肺癌的早期诊断。
Int J Med Sci. 2020 Jun 21;17(11):1561-1568. doi: 10.7150/ijms.47463. eCollection 2020.
6
Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?循环 ABCC3 转运蛋白自身抗体是否为肺癌的潜在生物标志物?
J Cancer Res Clin Oncol. 2012 Oct;138(10):1737-42. doi: 10.1007/s00432-012-1260-9. Epub 2012 Jun 15.
7
Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.开发一组血清 IgG 和 IgA 自身抗体用于结肠癌的早期诊断。
Int J Med Sci. 2020 Sep 25;17(17):2744-2750. doi: 10.7150/ijms.50169. eCollection 2020.
8
Anti-FDX1 Autoantibody as a Potential Biomarker for Non-Small Cell Lung Cancer Detection.抗FDX1自身抗体作为非小细胞肺癌检测的潜在生物标志物
Cancer Epidemiol Biomarkers Prev. 2025 Mar 3;34(3):439-447. doi: 10.1158/1055-9965.EPI-24-1096.
9
The diagnostic efficiency of seven autoantibodies in lung cancer.七种自身抗体在肺癌中的诊断效率。
Eur J Cancer Prev. 2020 Jul;29(4):315-320. doi: 10.1097/CEJ.0000000000000559.
10
Multisite DNA methylation alterations of peripheral blood mononuclear cells serve as novel biomarkers for the diagnosis of AIS/stage I lung adenocarcinoma: a multicenter cohort study.外周血单个核细胞的多部位DNA甲基化改变作为早期侵袭性肺腺癌/Ⅰ期肺腺癌诊断的新型生物标志物:一项多中心队列研究
Int J Surg. 2025 Jan 1;111(1):40-54. doi: 10.1097/JS9.0000000000002101.

本文引用的文献

1
The Proposed Ninth Edition TNM Classification of Lung Cancer.肺癌第九版 TNM 分期系统。
Chest. 2024 Oct;166(4):882-895. doi: 10.1016/j.chest.2024.05.026. Epub 2024 Jun 15.
2
Decoding the autoantibody reactome.解析自身抗体反应组
Science. 2024 Feb 16;383(6684):705-707. doi: 10.1126/science.abn1034. Epub 2024 Feb 15.
3
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer.血清蛋白酶-3水平升高预示转移性结直肠癌患者无进展生存期较差且贝伐单抗疗效较低。
BMC Cancer. 2024 Feb 2;24(1):165. doi: 10.1186/s12885-024-11924-4.
4
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
5
Combinational antibody detection approach increases the clinical validity of colorectal cancer screening.联合抗体检测方法提高了结直肠癌筛查的临床有效性。
J Clin Lab Anal. 2023 Nov;37(21-22):e24978. doi: 10.1002/jcla.24978. Epub 2023 Nov 14.
6
The global burden of lung cancer: current status and future trends.全球肺癌负担:现状与未来趋势。
Nat Rev Clin Oncol. 2023 Sep;20(9):624-639. doi: 10.1038/s41571-023-00798-3. Epub 2023 Jul 21.
7
Diagnostic Value of Seven Autoantibodies Combined with CEA and CA199 in Non-Small Cell Lung Cancer.七种自身抗体联合 CEA 和 CA199 对非小细胞肺癌的诊断价值。
Clin Lab. 2023 May 1;69(5). doi: 10.7754/Clin.Lab.2022.220728.
8
Identification of PRTN3 as a novel biomarker for the diagnosis of early gastric cance.鉴定PRTN3作为早期胃癌诊断的新型生物标志物。
J Proteomics. 2023 Apr 15;277:104852. doi: 10.1016/j.jprot.2023.104852. Epub 2023 Feb 17.
9
Anti-Proteinase 3 Antibodies as a Biomarker for Ulcerative Colitis and Primary Sclerosing Cholangitis in Children.抗蛋白酶 3 抗体作为儿童溃疡性结肠炎和原发性硬化性胆管炎的生物标志物。
J Pediatr Gastroenterol Nutr. 2022 Apr 1;74(4):463-470. doi: 10.1097/MPG.0000000000003359. Epub 2021 Nov 24.
10
Serum Biomarker Panel for Rapid Early Diagnosis of Lung Cancer.血清生物标志物面板用于快速早期诊断肺癌。
Curr Cancer Drug Targets. 2023;23(7):534-546. doi: 10.2174/1568009622666220523154333.